Comparison guide
Berberine or dihydroberberine?
Dihydroberberine gets more berberine into the blood than berberine HCl, whose oral bioavailability is under 1%. The catch is that the glucose and cholesterol evidence comes from standard berberine, and the one human trial of dihydroberberine found better absorption did not mean better glucose control.
The options, compared
| Option | Evidence | Best for | The honest note | |
|---|---|---|---|---|
| Berberine | Moderate evidence | Most people considering berberine | The form used in the glucose and lipid trials, typically 500 mg two or three times daily with meals. The effects are real but the trials are small, short and at high risk of bias, and GI upset is common at higher doses. | View |
| Dihydroberberine | Limited evidence | Absorption edge, no outcome data | Dosed at 100–200 mg, it produced higher plasma berberine than 500 mg of berberine HCl, but in that same trial neither form improved the glucose response to a meal. The 5x potency conversion printed on labels is a marketing extrapolation. | View |
Our verdict
If you use berberine, take standard berberine HCl at the doses the outcome trials used; dihydroberberine is a pharmacokinetic upgrade with no clinical outcome data yet. Either way, treat it as a drug: both forms interact with statins, cyclosporine and many other medicines, add to the effect of diabetes drugs, and should be avoided in pregnancy, breastfeeding and infants.